Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer

Dis Esophagus. 2016 Feb-Mar;29(2):116-30. doi: 10.1111/dote.12315. Epub 2015 Jan 21.

Authors

C Yip^{1

2}, G J R Cook¹, D B Landau^{1

3}, A Davies⁴, V Goh^{1

5}

Affiliations

¹ Division of Imaging Sciences and Biomedical Engineering, King's College London, London, UK.
² Department of Radiation Oncology, National Cancer Center, Singapore.
³ Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁴ Department of General Surgery, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁵ Department of Radiology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

PMID: 25604614
DOI: 10.1111/dote.12315

No abstract available

Keywords: esophageal cancer; imaging; neoadjuvant therapy; response.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Endosonography*
Esophageal Neoplasms / diagnostic imaging*
Esophageal Neoplasms / therapy
Fluorodeoxyglucose F18
Humans
Magnetic Resonance Imaging*
Multidetector Computed Tomography*
Neoadjuvant Therapy
Positron-Emission Tomography / methods*

Substances

Fluorodeoxyglucose F18

Grants and funding